Home > Organization > Divisions and Independent Research Units > Group for Translational Research > Division of Cancer Pathophysiology > Research Projects > Molecular analysis of onset and continuance of pain in cancer patients and innovation of novel ana
Molecular analysis of onset and continuance of pain in cancer patients and innovation of novel ana
Cancer patients are suffering from several types of pain including cancer, itself, and during therapy such as chemotherapy. We are developing novel analgesics specific to each pain by investigation of molecular analysis of characteristics of the pain. For instance, since 2015 we have been continuing to develop a novel analgesic for oral mucositis in cancer patients supported by the Drug Discovery Support Promotion Project, AMED. Another project aims to develop novel compounds for the inhibition of platelet-activating factor (PAF) signaling loop, the pathway causing progression of severe chronic pain supported by the Project for Cancer Research and Therapeutic Evolution, AMED.